Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Leucovorin × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 17 Stomach Neoplasms 10 Esophageal Neoplasms 7 Burkitt Lymphoma 7 Adenocarcinoma Of Esophagus 7 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Rectal Neoplasms 5 Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Cholangiocarcinoma 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Endometrial Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Pancreatic Ductal 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1

Interventions

durvalumab 3 Fulvestrant 3 Carboplatin 3 pembrolizumab 2 Pemetrexed 2 Cisplatin 2 trametinib 1 ribociclib 1 pralsetinib 1 palbociclib 1 exemestane 1 darolutamide 1 dabrafenib 1 ceralasertib 1 STX-478 1 Radiosurgery 1 Paclitaxel 1 Letrozole 1 Immunotherapy 1 Gemcitabine 1 Cetuximab 1 Anastrozole 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡